Title : ABCB1, ABCG2, and PTEN determine the response of glioblastoma to temozolomide and ABT-888 therapy.

Pub. Date : 2014 May 15

PMID : 24647572






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 ABCB1, ABCG2, and PTEN determine the response of glioblastoma to temozolomide and ABT-888 therapy. Temozolomide ATP binding cassette subfamily G member 2 (Junior blood group) Homo sapiens
2 Efficacy studies in WT and KO recipients and/or concomitant elacridar demonstrate that Abcb1/Abcg2 at the BBB and in tumor cells impair TMZ/ABT-888 combination treatment efficacy. Temozolomide ATP binding cassette subfamily G member 2 (Junior blood group) Homo sapiens
3 Importantly, inhibition of ABCB1 and ABCG2 (by elacridar) may improve the efficacy of TMZ/ABT-888 therapy in all glioblastoma patients. Temozolomide ATP binding cassette subfamily G member 2 (Junior blood group) Homo sapiens